title: Latent myeloproliferative disorder revealed by the JAK2-V617F mutation and endogenous megakaryocytic colonies in patients with splanchnic vein thrombosis.
authors.forename: Marjorie
authors.initials: M
authors.lastname: Boissinot
authors.forename: Eric
authors.initials: E
authors.lastname: Lippert
authors.forename: Francois
authors.initials: F
authors.lastname: Girodon
authors.forename: Irene
authors.initials: I
authors.lastname: Dobo
authors.forename: Marc
authors.initials: M
authors.lastname: Fouassier
authors.forename: Claude
authors.initials: C
authors.lastname: Masliah
authors.forename: Vincent
authors.initials: V
authors.lastname: Praloran
authors.forename: Sylvie
authors.initials: S
authors.lastname: Hermouet
mesh_terms: D000328:Adult; D000368:Aged; D019943:Amino Acid Substitution; D005260:Female; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics*; D008232:Lymphoproliferative Disorders / Q000235:genetics*; D008297:Male; D008533:Megakaryocytes / Q000502:physiology*; D008875:Middle Aged; D013152:Splanchnic Circulation; D013927:Thrombosis / Q000209:etiology / Q000235:genetics*
chemical_list: C507924:JAK2 protein, human; D053614:Janus Kinase 2